Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Attentive to clients needs and very supportive Increased energy after the shots The consultation was easy and pleasant
We prescribe and monitor peptide therapy in Park Ridge, IL
Allison Whitten Pfizer's LITFULO meets primary endpoints in Phase 3 vitiligo trials Pfizer reported topline results from two Phase 3 trials of LITFULO (ritlecitinib) in nonsegmental vitiligo, with both the 50 and 100 milligram once-daily doses meeting co-primary endpoints for facial and total body repigmentation over placebo at Week 52
Data confirmed the findings from the previous trial
US$ 20.06
US$ 29.05
US$ 24.99
US$ 27.51
